Results 91 to 100 of about 3,025,811 (189)

DNA Vaccines in the Post-mRNA Era: Engineering, Applications, and Emerging Innovations. [PDF]

Int J Mol Sci
Neeli P, Chai D, Roy D, Prajapati S, Bonam SR.   +4 more
europepmc   +1 more source

Chitosan nanoparticles as next-generation carriers for veterinary DNA vaccines: Mechanisms, immune responses, and translational prospects. [PDF]

Vet World
González-Lozano M, Cano-Buendía JA.
europepmc   +1 more source

Comparison of DNA vaccines with AddaS03 as an adjuvant and an mRNA vaccine against SARS-CoV-2. [PDF]

iScience, 2023
Neeli P, Chai D, Wang X, Sobhani N, Udeani G, Li Y.   +5 more
europepmc   +1 more source

A cGAS-Independent STING/IRF7 Pathway Mediates the Immunogenicity of DNA Vaccines

Journal of Immunology, 2016
J. Suschak, Shixia Wang, K. Fitzgerald, Shan Lu   +3 more
semanticscholar   +1 more source

Development of RALA-Based Mannosylated Nanocarriers for Targeted Delivery of Minicircle DNA Vaccines Encoding HPV-16 Oncogenes. [PDF]

Vaccines (Basel)
Giusti A, Eusébio D, Costa M, Silveira I, Biswas S, Costa D, Sousa Â.   +6 more
europepmc   +1 more source

Amyloidogenic propensity of self-assembling peptides and their adjuvant potential for use as DNA vaccines. [PDF]

Acta Biomater, 2023
Shrimali PC, Chen S, Das A, Dreher R, Howard MK, Ryan JJ, Buck J, Kim D, Sprunger ML, Rudra JS, Jackrel ME.   +10 more
europepmc   +1 more source

DNA vaccines targeting hemagglutinin from 18 subtypes of influenza A virus to antigen-presenting cells confer broad protection. [PDF]

Mol Ther Nucleic Acids
Anderson AM, Tjärnhage E, Hinke DM, Braathen R, Grodeland G, Bogen B.   +5 more
europepmc   +1 more source

Thermostable unit solid dose formulations for subcutaneous administration of DNA vaccines. [PDF]

Mol Ther Nucleic Acids
Garcia-Valtanen P, Yeow AEL, Mekonnen ZA, Whelan DM, Santos R, Al-Delfi Z, Rodrigues S, Gavan P, Howard K, Masavuli MG, Grubor-Bauk B.   +10 more
europepmc   +1 more source

Both chimpanzee adenovirus-vectored and DNA vaccines induced long-term immunity against Nipah virus infection. [PDF]

NPJ Vaccines, 2023
Lu M, Yao Y, Zhang X, Liu H, Gao G, Peng Y, Chen M, Zhao J, Zhang X, Yin C, Guo W, Yang P, Hu X, Rao J, Li E, Chen T, Chiu S, Wong G, Yuan Z, Lan J, Shan C.   +20 more
europepmc   +1 more source

Preclinical and clinical development of DNA vaccines for prostate cancer.

Urologic oncology, 2016
Viswa Colluru, L. Johnson, Brian M Olson, D. McNeel   +3 more
semanticscholar   +1 more source